- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/24 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 237/24
Total number of patents in this class: 301
10-year publication summary
|
15
|
16
|
18
|
23
|
24
|
17
|
28
|
25
|
24
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4751 |
25 |
| Syngenta Crop Protection AG | 6710 |
14 |
| Celgene Quanticel Research, Inc. | 154 |
10 |
| Bayer AG | 3499 |
8 |
| Nihon Nohyaku Co., Ltd. | 325 |
8 |
| Eonhf, Inc. | 45 |
8 |
| Novartis AG | 10251 |
6 |
| Boehringer Ingelheim International GmbH | 4493 |
5 |
| Bayer Cropscience AG | 1841 |
5 |
| FMC Corporation | 806 |
5 |
| Theravance Biopharma R&D IP, LLC | 362 |
5 |
| Janssen Pharmaceutica N.V. | 3162 |
4 |
| Sumitomo Chemical Company, Limited | 8968 |
4 |
| The Scripps Research Institute | 1340 |
4 |
| UniQuest Pty Limited | 35 |
4 |
| Lieber Institute, Inc. | 45 |
4 |
| F. Hoffmann-La Roche AG | 7819 |
3 |
| Syngenta Participations AG | 1516 |
3 |
| Cytokinetics, Inc. | 251 |
3 |
| Incyte Corporation | 1067 |
3 |
| Other owners | 170 |